1. Home
  2. DRVN vs SNDX Comparison

DRVN vs SNDX Comparison

Compare DRVN & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$14.97

Market Cap

2.0B

ML Signal

HOLD

Logo Syndax Pharmaceuticals Inc.

SNDX

Syndax Pharmaceuticals Inc.

HOLD

Current Price

$19.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRVN
SNDX
Founded
1972
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
DRVN
SNDX
Price
$14.97
$19.70
Analyst Decision
Buy
Strong Buy
Analyst Count
8
13
Target Price
$18.33
$38.69
AVG Volume (30 Days)
765.5K
1.9M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
146.70
11.56
EPS
0.33
N/A
Revenue
$1,862,438,000.00
$172,352,000.00
Revenue This Year
N/A
$107.19
Revenue Next Year
$1.53
$41.88
P/E Ratio
$43.55
N/A
Revenue Growth
N/A
627.84
52 Week Low
$9.80
$9.49
52 Week High
$19.74
$25.59

Technical Indicators

Market Signals
Indicator
DRVN
SNDX
Relative Strength Index (RSI) 56.65 38.51
Support Level $14.34 $19.28
Resistance Level $15.90 $22.40
Average True Range (ATR) 0.61 1.10
MACD -0.12 -0.48
Stochastic Oscillator 61.88 7.28

Price Performance

Historical Comparison
DRVN
SNDX

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: